No abstract available
Keywords:
allogeneic transplantation; checkpoint inhibitor; nivolumab; progressive multifocal leukoencephalopathy.
MeSH terms
-
Antineoplastic Agents, Immunological / pharmacology
-
Antineoplastic Agents, Immunological / therapeutic use*
-
Female
-
Humans
-
Leukoencephalopathy, Progressive Multifocal / drug therapy*
-
Leukoencephalopathy, Progressive Multifocal / etiology*
-
Leukoencephalopathy, Progressive Multifocal / pathology
-
Middle Aged
-
Nivolumab / pharmacology
-
Nivolumab / therapeutic use*
-
Transplantation, Homologous / adverse effects*
Substances
-
Antineoplastic Agents, Immunological
-
Nivolumab